Share Twitter LinkedIn Facebook Email Saveri Bhattacharya, DO, Thomas Jefferson University, talks about Vaccine Immunotherapy with Cytoxan & Interferon | Eventually add Ipilimumab or Pembrolizumab at Annual Meeting 2018 Advertisement